Heartflow is a pioneering medical technology company focused on enhancing the diagnosis and management of coronary artery disease, the leading cause of death globally. Utilizing advanced AI technology, Heartflow's flagship product, the Heartflow FFR_CT Analysis, offers a non-invasive cardiac test that generates a detailed, color-coded 3D model of a patient's coronary arteries, helping clinicians assess the impact of blockages on heart blood flow. The company is recognized internationally for its innovative healthcare solutions and is supported by medical societies worldwide. With a growing pipeline of products and a commitment to revolutionizing precision heart care, Heartflow has positively impacted over 400,000 patients across the US, UK, Europe, Japan, and Canada. The company fosters a collaborative environment for talented individuals passionate about developing cutting-edge web applications and 3D medical imaging.